Increased adoption of genome-based medicine in emerging countries presents opportunities

European single cell multi-omics market

DUBLIN, Feb. 26, 2024 (Globe Newswire) — The “European Single Cell Multi-omics Market: Analysis and Forecast, 2023-2033” report has been added. ResearchAndMarkets.com Recruitment.

The European single cell multi-omics market was valued at $350 million in 2023 and is expected to reach $1.71 billion by 2033, growing at a CAGR of 17.23% during the forecast period 2023-2033. Masu. This market is driven by several factors, including the increasing prevalence of large-scale genomics research utilizing single-cell RNA-seq (Sc-RNA), and the shift to personalized medicine using single-cell multi-omics approaches in disease screening and diagnosis. We have achieved growth due to these factors. , and the increasing adoption of single-cell multi-omics in drug development.

Market introduction

The European single-cell multi-omics market is witnessing significant growth due to advances in genomics research and increasing adoption of personalized healthcare. Researchers are leveraging single-cell multi-omics technology to gain deeper insight into the molecular mechanisms of disease and enable more accurate diagnosis and treatment. Additionally, these technologies are revolutionizing drug development by enabling highly targeted therapeutic approaches. Europe, with its robust medical infrastructure and research capabilities, is at the forefront of the implementation of single-cell multi-omics. Collaboration between academic institutions, biotech companies, and medical institutions is fostering innovation, expanding the scope of applications for these cutting-edge technologies, and contributing to market expansion.

market segmentation

Segmentation 1: By country

• Germany

• England

• France

• Italy

• Spain

• Rest of Europe

Overview of key market players and competition

The companies featured are selected based on information gathered from leading experts and an analysis of the company’s scope, product portfolio, and regional presence. Some of the prominent companies in this market are:

story continues

key attributes

business driver

• A growing number of large-scale genomics studies leverage single-cell RNA-seq (SC-RNA)

• Use of single-cell multi-omics approaches in disease screening and diagnosis leading to the transition to personalized medicine

• Increasing use of single-cell multi-omics in drug development

• Collaboration between technology providers and life science companies to accelerate single-cell multi-omics research

business limits

business chance

• Expansion to new research applications such as single-cell metabolomics

• Increased adoption of genome-based medicine in emerging countries

For more information about this report, please visit https://www.researchandmarkets.com/r/i6y0b8.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900